Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Anacor Pharmaceuticals
Biotech
AN2 upsizes IPO, teeing up bid to revitalize ex-GSK, Pfizer drug
AN2 has upsized its IPO, reeling in $69 million for a pivotal trial of an antibiotic it picked up from Pfizer’s Anacor.
Nick Paul Taylor
Mar 25, 2022 8:45am
Realm scraps eye drug after midphase flop, sinking stock
Mar 12, 2018 9:00am
Pfizer pays $5.2B for eczema specialist Anacor
May 16, 2016 7:14am
